Overview

The GMO Quality Strategy seeks to generate total return by investing primarily in equities the Focused Equity team believes to be of high quality.
 
The team believes that companies with established track records of historical profitability and strong fundamentals – high quality companies – are able to outgrow the average company over time and are therefore worth a premium price. The Strategy’s disciplined approach uses both quantitative and fundamental techniques to assess the relative quality and valuation of global companies and aims to exploit a long-term investment horizon while withstanding short-term volatility.
 

Quarterly Update | Video

1Q 2022 Strategy Review

In the latest quarterly update, GMO’s Focused Equity team reviews Strategy performance over the prior quarter, current positioning, and our outlook moving forward.

Watch Now


 

Facts

Performance

Documents

Literature

Fact Sheet Download
Product Primer Download
ESG Dashboard Download
GIPS® Composite Report Download
Composite Descriptions Download
Download All Download

Downloads

Performance Download
Portfolio Composition Download
Preliminary Performance Download
Download All Download

Commentary & Attribution

Commentary - Monthly Download
Commentary - Quarterly Download
Year-End Letter Download
Attribution - Monthly Download
Attribution - Quarterly Download
Attribution - YTD Download
Download All Download

Risks

Risks associated with investing in the Strategy may include Market Risk - Equities, Management and Operational Risk, Focused Investment Risk, Non-U.S. Investment Risk, and Currency Risk.

Related Reading

Read More GMO Research